Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to Innovative ImmunoOncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma’.
The above information is a part of company’s filings submitted to BSE.